Munuaisten terveys: Syö hyvin, elä hyvin
"Muuaisten terveys: syö hyvin, elä hyvin": Ohjelma vähentää munuaisvaurioita ja varhaista kroonisen taudin etenemistä ravitsemuksen ja terveyskumppanin empaattisen tuen avulla
This two-arm, parallel randomized trial study will assess the efficacy of a 6-month (26 weeks) community-based program in reducing kidney injury (as Urine Albumin to Creatinine ratio, uACR), cardiovascular risk (as Hemoglobin A1C and blood pressure), mental health (as PHQ-8) and diet quality (as fruits and vegetables intake and Healthy Eating Index) in community-dwelling, low-income adults diagnosed with early chronic kidney disease (stages 2 or 3 and not on kidney replacement therapies) compared to educational materials and usual care alone.
Tutkimuksen yleiskatsaus
Tila
Tila
Ehdot
Ehdot
Interventio / Hoito
Interventio / Hoito
- Käyttäytyminen: 1. Welcome package
- Käyttäytyminen: 2. Welcome information (phone or text)
- Käyttäytyminen: 3. Produce delivery + Recipes customized to produce
- Käyttäytyminen: 4. E-gift cards to a grocery store of choice
- Käyttäytyminen: 5. Personalized practical & emotional support through a dedicated health partner
Yksityiskohtainen kuvaus
This study tests a community-based program aimed at supporting adults with early-stage chronic kidney disease to change their eating habits to reduce the likelihood of kidney injury progression.
The program components were design to reduce barriers to a) eating healthier, kidney-friendly foods through the direct provision of fruits and vegetables, grocery store e-gift cards, kidney-friendly recipes, and food preparation tips; b) learning about kidney disease and the role of healthy eating in slowing its progression through educational materials; and c) social connection through empathetic relational phone calls and SMS texts from a dedicated "Health Partner".
Over a period of 6 months (26 weeks), participants randomized to the intervention arm will receive:
- kidney-friendly produce (fruits and vegetables) delivered at their preferred location
- recipes and tips on food preparation tailored to the produce
- grocery store electronic gift cards
- educational materials on CKD and disease management
- personalized practical and emotional support through a dedicated Health Partner
Researchers will see if participation in the program (intervention) reduces markers of kidney injury (Albumin:Creatinin ratio) and cardiovascular disease risk and improves diet (particularly fruits and vegetables intake) and mental health when compared to usual care (control).
Opintotyyppi
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Ilmoittautuminen
Vaihe
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Texas
-
Houston, Texas, Yhdysvallat, 77026
- Harris Health System's Outpatient Center
-
Houston, Texas, Yhdysvallat, 77047
- Harris Health System's Martin Luther King Jr. Health Center
-
Houston, Texas, Yhdysvallat, 77054
- Harris Health System's Smith Clinic
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Adult (18 years of age or older)
- Primary care visit at either one of the three partner clinics from Harris Health [Smith Clinic, Harris Health Outpatient Center (located on the LBJ campus), or Martin Luther King Jr. Health Center (MLK)] and a primary care patient within Harris Health System
- Have had at least 1 visit in the past 18 months with prior history in the clinic (i.e., not first visit)
- Diagnosis of CKD (Stage 2, 3a, and 3b) as defined by estimated Glomerular Filtration Rate (eGFR) ≥ 30 and <90 mL/min/1.73 m2 OR CDK 1 or undiagnosed with urine Albumin Creatinine Ratio ≥ 30 mg/g
- Within the past 12 months, the most current serum K+ ≤ 4.6 mEq/L
- English or Spanish speaking
- Ability to participate in the program at least 6 months
- Ability to clean, prepare, refrigerate/freeze food products that are given to them
- Have access to receive SMS text messages
- Location of preferred produce bag delivery within an available delivery zone
Exclusion Criteria:
- CKD 4, ESRD or on dialysis.
- Taking certain medications chronically (more than twice a week for 90 days) that may interfere with K+ metabolism (such as non-steroidal anti-inflammatory drugs (NSAIDs), as self-reported during enrollment screening
- Taking mineralocorticoid receptor antagonists
- Taking Warfarin
- Diagnosis of any specific kidney conditions (such as polycystic kidney disease, glomerulonephritis, Lupus associated with Nephritis, Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)) that would contraindicate study participation as determined by physician
- Medical history of organ transplant that would contraindicate study participation as determined by physician
- Received immunotherapy for primary or secondary kidney disease within 6 months prior to enrolment
- Diagnostic of heart failure conditions Class IV in the New York Heart Association (NYHA) functional classification
- Had myocardial infarction, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks prior to enrolment
- Had coronary revascularization (PCI, CABG) or valvular repair within 12 weeks prior to enrolment
- On active hospice care as self-reported during enrollment screening
- Diagnosis of active malignancy requiring treatment that would contraindicate study participation as determined by physician
- Has decompensated cirrhosis as determined by physician
- Cognitive impairment that would contraindicate study participation as self-reported during enrollment screening
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kaksinkertainen
Aseiden lukumäärä
Aseet ja interventiot
Osallistujaryhmä / ArmOsallistujaryhmä / Arm |
Interventio / HoitoInterventio / Hoito |
|---|---|
|
Kokeellinen: Arm 1: Intervention + usual care
|
At the end of the baseline data collection visit at the clinic, the Research Staff will hand the participant a welcome packet that includes:
Those allocated to the intervention arm will receive a welcome call from the Program Staff to provide further details and expectations about the program (such as delivery details and schedule). Those allocated to the control arm will receive an SMS text that informs them of their arm allocation, what to expect and a phone number to call for questions.
Five (5) e-gift cards to a major local grocery retailer chosen by the participant (from 3 options) at the following frequency:
|
|
Muut: Arm 2: Educational materials + usual care
|
At the end of the baseline data collection visit at the clinic, the Research Staff will hand the participant a welcome packet that includes:
Those allocated to the intervention arm will receive a welcome call from the Program Staff to provide further details and expectations about the program (such as delivery details and schedule). Those allocated to the control arm will receive an SMS text that informs them of their arm allocation, what to expect and a phone number to call for questions. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Urine albumin:creatinine ratio (UACR)
Aikaikkuna: Baseline, 3 months, 6 months
|
Marker of kidney damage and a useful predictor of cardiovascular (CV) events in adults. Uses spot urine to estimate 24-hour urine albumin excretion. UACR > 30 mg/g indicates kidney damage. |
Baseline, 3 months, 6 months
|
Toissijaiset tulostoimenpiteet
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Hemoglobin A1C
Aikaikkuna: Baseline, 3 months, 6 months
|
Finger stick point-of-care portable device. Measures the average blood sugar levels over the past 3 months with a result in %. Higher A1C levels indicate poorer glycemic control and higher risk of diabetes complications. |
Baseline, 3 months, 6 months
|
|
Blood pressure (systolic/diastolic)
Aikaikkuna: Baseline, 3 months, 6 months
|
Direct measurement with automatic blood pressure cuff. |
Baseline, 3 months, 6 months
|
|
Food intake in the past 30 days as assessed by the Dietary Screener Questionnaire from NHANES 2009-10
Aikaikkuna: Baseline, 3 months, 6 months
|
30-day food frequency questionnaire (screener) that asks for frequency of intake in the past month (per month, per week, or per day) of 28 items such as cereal, red meat, fruits and vegetables. This study includes four food items linked to kidney health (and mostly acid-inducing): eggs, chicken/turkey, fish, and cheese. Questions are asked in the same fashion as the other questions in the tool. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of fruits and vegetables consumption
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake from the Dietary Screener Questionnaire, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Reported per fruits and vegetables as cup equivalents/day. |
Baseline, 3 months, 6 months
|
|
Anxiety as measured by scores on the Generalized Anxiety Disorder 7-item (GAD-7)
Aikaikkuna: Baseline, 3 months, 6 months
|
Self-administered. Based on some of the DSM-V criteria for General Anxiety Disorder to identify probable cases of GAD along with measuring anxiety symptom severity. Responders are asked to rate the frequency of anxiety symptoms in the last 2 weeks on a Likert scale ranging from 0 (not at all) to 3 (nearly every day). Items are summed to provide a total score (0-21) to inform severity (1-4 minimal symptoms; 5-9 mild symptoms; 10-14 moderate symptoms; 15-21 severe symptoms). |
Baseline, 3 months, 6 months
|
|
Depressive symptoms as measured by scores on the Patient Health Questionnaire 8-item (PHQ-8)
Aikaikkuna: Baseline, 3 months, 6 months
|
Self-administered. Based on the nine DSM-V criteria listed under criterion A for Major Depressive Disorder. Responders are asked to rate the frequency of depression symptoms in the last 2 weeks on a Likert scale ranging from 0 (not at all) to 3 (Nearly every day). The sum of responses to each item yields a total score that screens for depression and its severity: not depressed (0-2), mild (3-5), moderate (6-8), and severe (9-12). |
Baseline, 3 months, 6 months
|
|
Loneliness measured by scores on the 3-item UCLA Loneliness Scale
Aikaikkuna: Baseline, 3 months, 6 months
|
Self-administered. Respondents rate each item as 'Never' , 'Rarely', 'Sometimes' or 'Often'. Scores range from 3 to 9. Higher numbers imply greater loneliness. |
Baseline, 3 months, 6 months
|
Muut tulostoimenpiteet
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Social engagement as measured by the Lubben Social Network scale 6-item
Aikaikkuna: Baseline, 6 months
|
Self-administered. The LSNS-6 is a self-report measure of social engagement with family and friends. The sum of the all items yields a total score that ranges between 0 and 30, with a higher score indicating more social engagement. |
Baseline, 6 months
|
|
Perception of kidney disease and role of diet as measured by the Brief Illness Perception Questionnaire
Aikaikkuna: Baseline, 6 months
|
Self-administered. Answers are on a 0-10 sliding scale, except for one open-ended ranking question. Increases in item scores represent linear increases in the dimension measured. It contains 9 questions addressing the individual's cognitive perceptions, control over illness, beliefs about the effectiveness of treatment, experience of symptoms and emotional aspects. To better tailor it to the study population, "illness" was replaced by "kidney problem". And one question about perceived impact of food on disease was added to tailor it to the intervention. |
Baseline, 6 months
|
|
General health and quality of life as measured by scores on the MOS Short-form 12-item (SF-12)
Aikaikkuna: Baseline, 6 months
|
Self-administered. Measures physical and mental health status. Summary scores range from 0-100, with higher scores indicating a better self-reported level of health. |
Baseline, 6 months
|
|
Food security status as assessed by the USDA Food Security Survey Module: Six-Item Short Form
Aikaikkuna: Baseline, 6 months
|
Self-administered. Self-report assessment of access to food in the past 30 days. The sum of affirmative responses to the six questions in the module yields the household's raw score on the scale. Scores can range from 0 to 6, with higher scores indicating lower food security. |
Baseline, 6 months
|
|
Estimated Glomerular Filtration Rate (eGFR)
Aikaikkuna: As available 18 months before enrollment in the study and 15 months after study participation ends
|
Obtained from Electronic Health Records. Any lab result available from 18 months prior to and 15 month post enrollment date will be obtained for study participants. |
As available 18 months before enrollment in the study and 15 months after study participation ends
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of dairy consumption
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Food group of dairy is reported as cup equivalents/day. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of added sugars
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Reported added sugars as teaspoon equivalents/day. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of whole grains
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Reported whole grains as ounce equivalents/day. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of fiber
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Reported fiber as g/day. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of calcium
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Reported calcium as mg/day. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as frequency of red and processed meat consumption
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. And reported red meat and processed meat as frequencies (times per day). |
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of eggs
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Added for its acid-inducing properties in chronic kidney disease. Reported as frequencies only (times per day) and amount. |
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of chicken/turkey
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Added for its acid-inducing properties in chronic kidney disease. Reported as frequencies only (times per day). |
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of fish
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Added for its association with reduced CVD risk. Reported as frequencies only (times per day). |
Baseline, 3 months, 6 months
|
|
Changes in type of cheese consumption when reported
Aikaikkuna: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database. Soft vs. hard cheese types added for the acid-inducing properties of hard cheese in chronic kidney disease. Reported as type associated with dairy consumption. |
Baseline, 3 months, 6 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Sponsori
Yhteistyökumppanit
Yhteistyökumppanit
Tutkijat
Tutkijat
- Päätutkija: Maninder Kahlon, PhD, University of Texas at Austin
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Opiskelun aloitus
Ensisijainen valmistuminen (Arvioitu)
Ensisijainen valmistuminen
Opintojen valmistuminen (Arvioitu)
Opintojen valmistuminen
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Ensimmäinen Lähetetty
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin päivitys julkaistu
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
- Urogenitaaliset sairaudet
- Patologiset prosessit
- Miesten urogenitaaliset sairaudet
- Munuaissairaudet
- Urologiset sairaudet
- Naisten virtsa- ja sukupuolielinten sairaudet
- Naisten virtsa- ja sukupuolielinten sairaudet ja raskauden komplikaatiot
- Krooninen sairaus
- Sairauden ominaisuudet
- Virtsaamishäiriöt
- Urologiset ilmenemismuodot
- Munuaisten vajaatoiminta
- Patologiset tilat, merkit ja oireet
- Käyttäytyminen
- Merkit ja oireet
- Henkilökohtainen tyytyväisyys
- Munuaisten vajaatoiminta, krooninen
- Proteinuria
- Psykologinen hyvinvointi
Muut tutkimustunnusnumerot
Muut tutkimustunnusnumerot
- STUDY00002253
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .